Health and Wellness

Cash transfers boost health in low- and middle-income countries, data reveal

Government-led cash transfer programs have been shown to drive significant improvements in health outcomes across low- and middle-income countries (LMICs), according to a recent study published in The Lancet by

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

FDA advisory committee meetings fade as controversial decisions grow

The Trump administration recently organized a private press conference to address concerns about an experimental treatment for Huntington's disease developed

Federal autism advisory board cancels first public meeting since overhaul

A recent development in the world of autism research has caused quite a stir. The Interagency Autism Coordinating Committee (IACC),

Fauci, gender affirming care, Tylenol, autism: Morning Rounds

The battle over patient records and access to gender-affirming care continues as the Justice Department appeals a ruling that stopped

Trump gender-affirming care subpoenas reach appeals court stage

In a memo issued last spring, Attorney General Pam Bondi urged federal law enforcement to join President Trump’s efforts against

Tylenol orders for pregnant people dropped after Trump linked to autism

The importance of accurate information and evidence-based recommendations in public health cannot be overstated. In a recent study published in

TrumpRx’s slow start | STAT

Mary Talley Bowden, a physician who endured a lengthy legal battle with the Texas Medical Board over her license to

Jeffrey Epstein, George Church, nicotine: Morning Rounds

If you're looking to stay informed about the latest developments in health and medicine, look no further than STAT's free

TrumpRx: High expectations, but limited impact a month after launch

Many patients and experts are still skeptical about the potential benefits of TrumpRx, as the platform continues to face challenges